Overview


According to FutureWise analysis the market for Next-Generation IV Infusion Pumps in 2023 is US$ 2.26 billion, and is expected to reach US$ 3.61 billion by 2031 at a CAGR of 6.00%.

Advancements in the administration of intravenous medication, rising insistence for IV pumps from physicians, nurse anaesthetists and anaesthesiologist, soaring acceptance of smart pumps are some of the key factors responsible for the growth of the market. Furthermore, the emergence of reduction systems with less dosage errors shall bolster the next-generation IV infusion pumps market growth. IV infusion pumps are developed for improving system usability and infusion efficiency. These systems offer database of patient infusions for insightful decisions in managing chronic disorders. The emergence of dosage guidance in real-time and immediate feedback received from automatic drug libraries shall aid in the compliance of drugs used. This technology has also aided in the reduction of manual labour with the automatic documentation with EMR and BCMA. Such factors shall positively impact the market growth.

  • Baxter International Inc.
  • Becton Dickinson and Co.
  • Fresnius Kabi AG
  • B. Braun Melsungen AG
  • Smiths Medical
  • ICU Medical
  • iRadimed Corp.
  • Zyno Medical
  • Medtronic PLC
  • Terumo Corp.
  • Nipro Corp.
  • Summit Medical Products Inc.
  • Ambu A/S
  • Gamastech SRL
  • vTian
  • ACromed AG

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Large Volumetric Infusion Systems
  • Syringe Infusion Systems
  • Electronic Ambulatory Infusion Systems
  • Patient Controlled Analgesia Pumps
  • Disposable Elastomeric Infusion Systems
  • Implantable Infusion Systems
  • MRI-Compatible IV Infusion Pump Systems
  • IV Disposables

By Application

  • Clinical Nutrition
  • Pain Management
  • Chemotherapy
  • Antibiotic Management
  • Others

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Homecare Settings
  • Diagnostic Centers
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

The market is classified into product, application, end user and region. The product segment is categorised into large volumetric infusion systems, syringe infusion systems, electronic ambulatory infusion systems, patient controlled analgesia pumps, disposable elastomeric infusion systems, implantable infusion systems, MRI-compatible IV infusion pump system, IV disposables. The application segment is fragmented into clinical nutrition, pain management, chemotherapy, antibiotic management and others. The end user segment is categorised into hospitals, ambulatory surgical centres, homecare settings, diagnostic centres and others.

The North America region is predicted to hold the largest next-generation IV infusion pumps market share owing to the growing prevalence of appalling diseases, soaring geriatric population, rising access to advanced healthcare facilities, escalating insistence from clinicians. Furthermore, rising R D activities, improving insurance policies shall boost the market growth in the region.

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key market trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Next-Generation IV Infusion Pumps Market By Product, By Application, By End User And By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Next-Generation IV Infusion Pumps Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework on Country Level
         6.1 . Reimbursement Framework
         6.2 . Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1 . Market Driver Analysis
         1.2 . Market Restraint Analysis
         1.3 . Industry Challenges
  • 6.   Next-Generation IV Infusion Pumps Market Analysis tools

    •   1. Industry Analysis - Porter’s
         1.1 . Supplier Power
         1.2 . Buyer Power
         1.3 . Substitution Threat
         1.4 . Threat from new entrants
         1.5 . Competitive Rivalry
        2. Pestel Analysis
         2.1 . Political Landscape
         2.2 . Environmental Landscape
         2.3 . Social landscape
         2.4 . Technology landscape
         2.5 . Legal Landscape

  • 7.   Next-Generation IV Infusion Pumps Market, By Product Historical Analysis 2017-2022 and Forecast 2023-2031 (USD million)

    •   1. Large Volumetric Infusion Systems
        2. Syringe Infusion Systems
        3. Electronic Ambulatory Infusion Systems
        4. Electronic Ambulatory Infusion Systems
        5. Patient Controlled Analgesia Pumps
        6. Disposable Elastomeric Infusion Systems
        7. Implantable Infusion Systems
        8. MRI-Compatible IV Infusion Pump Systems
        9. IV Disposables

  • 8.   Next-Generation IV Infusion Pumps Market, By Application Historical Analysis 2017-2022 and Forecast 2023-2031 (USD million)

    •   1. Clinical Nutrition
        2. Pain Management
        3. Chemotherapy
        4. Antibiotic Management
        5. Others

  • 9.   Next-Generation IV Infusion Pumps Market, By End User Historical Analysis 2017-2022 and Forecast 2023-2031 (USD million)

    •   1. Hospitals
        2. Ambulatory Surgical Centers
        3. Homecare Settings
        4. Diagnostic Centers
        5. Others

  • 10.   North America Next-Generation IV Infusion Pumps Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.
         2.2. Canada
         2.3. Mexico
         2.4. Rest of North America
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Next-Generation IV Infusion Pumps Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Regional Market Trends
        3. Historical Market Size (US$ Million) Analysis By Country, 2017-2022
         3.1. Brazil
         3.2. Uruguay
         3.3. Argentina
         3.4. Rest of Latin America
        4. Market Size (US$ Million) Forecast for Latin America 2023-2031

  • 12.  Europe Next-Generation IV Infusion Pumps Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (US$ Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Switzerland
         2.6. Spain
         2.7. Russia
         2.8. Poland
         2.9. Rest of Western Europe
        3. Market Size (US$ Million) Forecast for North America 2023-2031

  • 13.  Asia Pacific Next-Generation IV Infusion Pumps Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. Singapore
         2.4. Korea
         2.5. India
         2.6. Australia and New Zealand
         2.7. ASEAN
         2.8. Rest of Asia Pacific
        3. Market Size (US$ Million) Forecast for North America 2023-2031

  • 14.  Middle East and Africa Next-Generation IV Infusion Pumps Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.  Market Share Analysis and Competitive Landscape

    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)

    •   1. Baxter International Inc.
         1.1. Company Overview (HQ, Business Segments, Employee Strength)
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Becton Dickinson and Co.
         2.1. Company Overview (HQ, Business Segments, Employee Strength)
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Fresnius Kabi AG
         3.1. Company Overview (HQ, Business Segments, Employee Strength)
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. B. Braun Melsungen AG
         4.1. Company Overview (HQ, Business Segments, Employee Strength)
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Smiths Medical
         5.1. Company Overview (HQ, Business Segments, Employee Strength)
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. ICU Medical
         6.1. Company Overview (HQ, Business Segments, Employee Strength)
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. iRadimed Corp.
         7.1. Company Overview (HQ, Business Segments, Employee Strength)
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Zyno Medical
         8.1. Company Overview (HQ, Business Segments, Employee Strength)
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Medtronic PLC
         9.1. Company Overview (HQ, Business Segments, Employee Strength)
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Terumo Corp.
         10.1. Company Overview (HQ, Business Segments, Employee Strength)
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Nipro Corp.
         11.1. Company Overview (HQ, Business Segments, Employee Strength)
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Summit Medical Products Inc.
         12.1. Company Overview (HQ, Business Segments, Employee Strength)
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Ambu A/S
         13.1. Company Overview (HQ, Business Segments, Employee Strength)
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Gamastech SRL
         14.1. Company Overview (HQ, Business Segments, Employee Strength)
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. vTian
         15.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. ACromed AG
         16.1. Company Overview (HQ, Business Segments, Employee Strength)
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview

  • 17.  Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.  Competitive Intelligence and Competitive Matrix

    •   1. Competitive Intelligence
        2. Competitive Matrix

  • 19.  Major Deals and Strategic Alliances Analysis

    •   1. Joint ventures
        2. Mergers and acquisitions
        3. Licensing and partnerships
        4. Technology Collaborations
        5. Strategic Divestments
        6. Market Entry Strategies

  • 20.  Relevant Case Studies and Latest News Updates

    •   

  • 21.  FutureWise SME Key Takeaway Points for Client

    •   


Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11